Results 41 to 50 of about 14,144 (194)
Background: This study aims to describe the incidence, mortality, and survival trends of vulvar and vaginal cancers in a population-based cohort from Northern Italy, with a particular focus on the development of second primary malignancies. Methods: Data
Isabella Bisceglia +6 more
doaj +1 more source
Incidence Trends of Vulvar Cancer in the United States: A 20‐Year Population‐Based Study
Background Despite being uncommon, vulvar cancer is a serious health concern with a 5‐year relative survival rate of 71%. Aims The objective was to investigate the incidence rates of this disease across different racial, ethnic, and histological ...
Seyed Ehsan Mousavi +4 more
doaj +1 more source
Vulvar Metastasis from Breast Cancer Treated with Abemaciclib plus Fulvestrant: A Case Report
Introduction: Breast cancer is the most common malignant tumor in women, affecting approximately 1 in 9 women worldwide. In contrast, vulvar cancer remains rare, accounting for
Clémence Vanden Berghe +6 more
doaj +1 more source
Atrophic vulvar lichen sclerosus evolving to an epidermoid carcinoma: about an uncommon case
Malignant tumors of the vulva are usually budding, ulcerated, or infiltrating. The fear of cancer must always be in mind, in front of any vulvar lesion.
Abderrahim Siati +4 more
doaj +1 more source
Risk of Cancer With Hormone Replacement Therapy: A Narrative Review
ABSTRACT Hormone replacement therapy (HRT) remains the cornerstone of menopausal symptom management, effectively alleviating vasomotor symptoms and genitourinary syndrome, whilst mitigating long‐term risks such as osteoporosis. However, despite an increasing body of evidence on the relative safety of HRT, earlier studies that demonstrated an increased ...
Gabriella Yongue +3 more
wiley +1 more source
Diabetes mellitus and the risk of vulvar and vaginal cancer: results from a large cohort study
Background Although diabetes mellitus has been associated with increased risk of several cancers, evidence in relation to vulvar and vaginal cancers has been limited and inconsistent.
Dagfinn Aune +7 more
doaj +1 more source
Vulvar cancer in Tunisia: Epidemiological and clinicopathological features multicentric study
Objective: To describe for the first time the epidemiologic and clinico-pathologic characteristics of vulvar cancer in Tunisia. Design: Two parts are distinguished in this study: Part1: Multicentric retrospective study about the characteristics of all ...
Mehdi Kehila, MD +12 more
doaj +1 more source
A Spotlight on Yolk‐sac Tumors: Molecular Pathology, Current Diagnostics, and Novel Therapeutics
ABSTRACT Background Yolk‐sac tumors are an aggressive subtype of testicular cancer that significantly contribute to disease progression and therapy resistance, especially in adults. While testicular cancer generally has high cure rates with cisplatin‐based treatment, adult yolk‐sac tumors often appear as components of mixed tumors with poor response to
Evangelos Prokakis +3 more
wiley +1 more source
WNL we never looked: vulvar carcinoma incidence after screening cutoff
The incidence of vulvar carcinoma increases with age, though elderly women receive less aggressive cancer therapies and fewer strategies aimed at cancer prevention.
Amaris N. Geisler, MD, Jodi E. Ganz, MD
doaj +1 more source
In women living with HIV, HPV clearance occurred after a mean of approximately 2 years under antiretroviral therapy. Baseline positivity for the high‐risk HPV pool was associated with delayed clearance, suggesting that HPV genotype may influence viral persistence more than immunovirological status in clinically stable patients.
Annunziata Carlea +10 more
wiley +1 more source

